HomeStrategyA $435 Million Bet on ‘Reversing Aging’ Strategy A $435 Million Bet on ‘Reversing Aging’ Strategy June 7, 2026 0 71 FacebookXPinterestWhatsApp Biotech startup NewLimit secures a major funding round after claiming a ‘breakthrough discovery’ of a prototype medicine that rewinds cellular aging in the liver. FacebookXPinterestWhatsApp Cody Previous articleDell sharpens data protection strategy as AI reshapes cyber resilienceNext articleLayoffs don’t have to feel inhumane RELATED ARTICLES Strategy Where Entrepreneurs Are Moving in 2026, And Why It’s Not Where You Might Expect Strategy At Age 25, She’s Turning the ‘Approachable’ Business That Started in Her Apartment Into Over $200K a Year: ‘Something People Genuinely Wanted’ Strategy The 2 SEO Signals Most Founders Underestimate (And Why They Compound) Strategy As Microsoft Eliminates Almost 5,000 Employees, Its HR Chief Makes a Statement About AI Must Read Syntiant, which makes low-power chips for on-device AI, files for initial public offering Tech Get to Know the ROI of New Flooring Finance Signs That It’s Time To Automate Your Business Operations Finance Samsung says memory chip demand will drive 19-fold jump in operating profit Tech Anthropic inks $19B AI data center lease with TeraWulf Tech